PTGX EPS Estimates
Protagonist Therapeutics, Inc.
$132.04
-$3.22(-2.38%)
50
Overall
40
Value
50
Tech
60
Quality
Market Cap
$8.62B
Volume
972.95K
52W Range
$77.00 - $160.81
Target Price
$176.88
PTGX EPS estimates: the consensus estimate for Protagonist Therapeutics, Inc.'s current fiscal year is $4.59 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
PTGX EPS Estimates
- EPS estimate, current quarter
- $2.58
- EPS estimate, next quarter
- $-0.38
- EPS estimate, current year
- $4.59
- EPS estimate, next year
- $0.11
- EPS growth, 3-year
- +0.00%
| Fiscal year | EPS |
|---|---|
| 2020 | $-1.92 |
| 2019 | $-2.98 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | PTGX | $132.04 | -2.4% | 972.95K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Protagonist Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW